ROBERT HERSHBERG Insider Trading $ADPT Adaptive Biotechnologies Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT HERSHBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT HERSHBERG. ROBERT HERSHBERG is Sr. VP & Chief Medical Officer in DENDREON CORP ($DNDN) and Director in NanoString Technologies Inc ($NSTG) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in RECURSION PHARMACEUTICALS, INC. ($RXRX).
ROBERT HERSHBERG in Adaptive Biotechnologies Corp
Trading Symbol: ADPTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT HERSHBERG: Director
Holdings: 3,504 shares
Latest Transaction: Mar 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT HERSHBERG in Adaptive Biotechnologies Corp
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADPT, DNDN, NSTG, RXRX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 53,000 | |
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 44.56 | 2,000 | 89,120 | 0 | 2 K to 0 (-100.00 %) |
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 53,000 | |
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 44.56 | 2,000 | 89,120 | 1,504 | 3.5 K to 1.5 K (-57.08 %) |
Mar 10 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 3,504 | 1.5 K to 3.5 K (+132.98 %) |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 55,000 | |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 65.45 | 2,000 | 130,900 | 1,504 | 3.5 K to 1.5 K (-57.08 %) |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 3,504 | 1.5 K to 3.5 K (+132.98 %) |
Feb 17 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 57,000 | |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 67.05 | 622 | 41,705 | 0 | 622 to 0 (-100.00 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 66.34 | 1,378 | 91,417 | 622 | 2 K to 622 (-68.90 %) |
Jan 20 2021 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 59,000 | |
Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 57.01 | 241 | 13,739 | 0 | 241 to 0 (-100.00 %) |
Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 55.78 | 1,759 | 98,117 | 241 | 2 K to 241 (-87.95 %) |
Dec 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Oct 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 63,000 | |
Oct 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 51.51 | 2,000 | 103,020 | 0 | 2 K to 0 (-100.00 %) |
Oct 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Sep 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 65,000 | |
Sep 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 42.58 | 2,000 | 85,160 | 0 | 2 K to 0 (-100.00 %) |
Sep 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Aug 19 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 67,000 | |
Aug 19 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 40.04 | 561 | 22,462 | 0 | 561 to 0 (-100.00 %) |
Aug 19 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 39.13 | 1,439 | 56,308 | 561 | 2 K to 561 (-71.95 %) |
Aug 19 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 69,000 | |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 44.58 | 500 | 22,290 | 0 | 500 to 0 (-100.00 %) |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 69,000 | |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 43.60 | 1,500 | 65,400 | 500 | 2 K to 500 (-75.00 %) |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 44.58 | 500 | 22,290 | 0 | 500 to 0 (-100.00 %) |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 43.60 | 1,500 | 65,400 | 500 | 2 K to 500 (-75.00 %) |
Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 71,000 | |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 43.42 | 984 | 42,725 | 0 | 984 to 0 (-100.00 %) |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 42.59 | 1,016 | 43,271 | 984 | 2 K to 984 (-50.80 %) |
Jun 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 73,000 | |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 36.10 | 398 | 14,368 | 0 | 398 to 0 (-100.00 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 73,000 | |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 35.23 | 400 | 14,092 | 398 | 798 to 398 (-50.13 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 36.10 | 398 | 14,368 | 0 | 398 to 0 (-100.00 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 34.14 | 1,202 | 41,036 | 798 | 2 K to 798 (-60.10 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 35.23 | 400 | 14,092 | 398 | 798 to 398 (-50.13 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 34.14 | 1,202 | 41,036 | 798 | 2 K to 798 (-60.10 %) |
May 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 25,000 | 11,250 | 75,000 | |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 29.77 | 25,000 | 744,250 | 0 | 25 K to 0 (-100.00 %) |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 25,000 | 11,250 | 25,000 | 0 to 25 K |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 25,000 | 11,250 | 75,000 | |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 29.77 | 25,000 | 744,250 | 0 | 25 K to 0 (-100.00 %) |
Apr 27 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 25,000 | 11,250 | 25,000 | 0 to 25 K |
Feb 18 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | A | 31.71 | 8,888 | 281,838 | 8,888 |
Page: 1